Sign up USA
Proactive Investors - Run By Investors For Investors

CannaJam connects small-cap cannabis companies with potential investors

Proactive Investors’ inaugural CannaJam event in New York featured speakers from iAnthus, Weekend Unlimited and Emerald Health Therapeutics
iAnthus Capital's Hadley Ford
iAnthus Capital's Hadley Ford addresses investors at Proactive Investors' CannaJam forum

Proactive Investors welcomed a bustling crowd of investors to its inaugural CannaJam Forum on Wednesday evening in New York City.

The event was equal parts fun and informative, bringing accredited investors and small-cap cannabis companies together in a close-knit setting that spilled out into the hallway.

Attendees were greeted by the lively sound of reggae music and an open bar and food sponsored by Callitas Health Inc (OTCQB:MPHMF).

After the opening remarks, Hadley Ford, CEO of iAnthus Capital Holdings (CSE:IAN) (OTCQB:ITHUF), took the floor to share a little about his cannabis cultivation company.

Headquartered in Midtown Manhattan, steps away from the event, the company owns processing and dispensary facilities in six states.

Ford, a 20-year healthcare veteran, was well-equipped to field questions from potential investors.

iAnthus recently broke ground on its 39,500 square foot medical cannabis cultivation and processing facility in Warwick, New York.

Next to present was Weekend Unlimited, a privately held company taking advantage of its cannabis industry connections to create a lifestyle brand.

Board member Brian Keane gave investors a run-down of the ins and outs of the company, eliciting a few laughs from the audience in the process.

The lighthearted company financed one of the world’s largest bongs, standing 24 feet tall and weighing nearly 800 pounds. Its bowl may hold at least a quarter-pound of marijuana.

Based in Vancouver, Weekend Unlimited has indoor cultivation and processing facilities in Washington state. It expects to go public next week, Keane said.

Rob Hill, chief financial officer of medical cannabis company Emerald Health Therapeutics

Rob Hill, chief financial officer of Emerald Health Therapeutics at CannaJam 2018

Last to address the room was Rob Hill, chief financial officer of medical cannabis company Emerald Health Therapeutics (TSX: EMH) (OTCQX:EMHTF).

Emerald Health is licensed under the Access to Cannabis for Medical Purposes Regulation to produce dried cannabis and cannabis oil for medical use.

The company has a strong focus on research, receiving a federal grant to explore cannabis strains and cultivation technologies.

Emerald Health is looking to expand its production capacity ahead of the impending legalization of recreational cannabis in Canada this October.

Proactive Investors’ next event is a CEO Investors’ Forum, a gathering of small-cap companies and investors, to be held on September 26.


Join our Crypto, Blockchain and Cannabis Telegram group here
View full PROAC profile View Profile

Proactiveinvestors Timeline


Related Articles

Lego ball
September 14 2018
The company's latest push is a joint venture agreement with US-based entertainment firm Three Six Zero, which has steered the careers of pop stars such as Calvin Harris
Throne of Glass
April 30 2018
Rowling, Rowling, Rowling ... keep those titles rolling. Mind you, it's not all about Ms Rowling; Sarah J Maas title revenues grew 47% in the first half of the financial year and dieters are gorging on Tom Kerridge's books
Media junkie
February 13 2018
In modern parlance, Ebiquity is making a pivot towards becoming the "world's leading tech-enabled marketing and media analytics consultancy"

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use